On the relevance of glycolysis process on brain gliomas

IEEE Journal of Biomedical and Health Informatics

Volumn 17, Issue 1, 2013, Pages 128-135

  Kounelakis, M G ^a   Zervakis, M E ^a   Giakos, G C ^b   Postma, G J ^c   Buydens, L M C ^c   Kotsiakis, X ^d  

^a TECHNICAL UNIVERSITY OF CRETE   (Greece)

^b The University of Akron   (United States)

^c RADBOUD UNIVERSITY NIJMEGEN   (Netherlands)

^d ENT Department of Chania General Hospital   (Greece)

Author keywords

Brain gliomas discrimination; Genomics; Glycolysis; Metabolomics

Indexed keywords

GENES; MAGNETIC RESONANCE; MAGNETIC RESONANCE SPECTROSCOPY; ONCOGENIC VIRUSES; TUMORS;

BIOLOGICAL EFFECTS; BIOLOGICAL VALIDATIONS; GENOMICS; GLYCOLYSIS; MAGNETIC RESONANCE SPECTROSCOPY IMAGING; METABOLOMICS; MICROARRAY EXPRESSIONS; THERAPEUTIC PROTOCOLS;

PATHOLOGY;

BIOLOGY; BRAIN TUMOR; CLUSTER ANALYSIS; FACTUAL DATABASE; GENE EXPRESSION PROFILING; GENETICS; GLIOMA; GLYCOLYSIS; HUMAN; METABOLISM; METABOLOME; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PROCEDURES; SUPPORT VECTOR MACHINE; ARTICLE; METHODOLOGY;

BRAIN NEOPLASMS; CLUSTER ANALYSIS; COMPUTATIONAL BIOLOGY; DATABASES, FACTUAL; GENE EXPRESSION PROFILING; GLIOMA; GLYCOLYSIS; HUMANS; MAGNETIC RESONANCE SPECTROSCOPY; METABOLOME; SUPPORT VECTOR MACHINES;

EID: 84885110378     PISSN: 21682194     EISSN: None     Source Type: Journal    
DOI: 10.1109/TITB.2012.2199128     Document Type: Article

References (47)

1. T. Shiraishi and K. Tabuchi, "Genetic alterations of human brain tumors as molecular prognostic factors," Neuropathology, vol. 23, pp. 95-108, Mar. 2003. (Pubitemid 36406794)
2. F. B. Furnari, T. Fenton, R. M. Bachoo, A. Mukasa, J. M. Stommel, A. Stegh, W. C. Hahn, K. L. Ligon, D. N. Louis, C. Brennan, L. Chin, R. A. DePinho, and W. K. Cavenee, "Malignant astrocytic glioma: Genetics, biology, and paths to treatment," Genes Develop., vol. 21, pp. 2683-2710, Nov. 2007. (Pubitemid 350070717)
3. H. Ohgaki and P. Kleihues, "Genetic alterations and signaling pathways in the evolution of gliomas," Cancer Sci., vol. 100, pp. 2235-2241, Dec. 2009.
4. R. G. Jones and C. B. Thompson, "Tumor suppressors and cell metabolism: A recipe for cancer growth," Genes Develop., vol. 23, pp. 537-548, Mar. 2009.
5. J. W. Kim and C. V. Dang, "Cancer's molecular sweet tooth and the Warburg effect," Cancer Res., vol. 66, pp. 8927-8930, Sep. 2006.
6. O. Warburg, "On the origin of cancer cells," Science, vol. 123, pp. 309-314, Feb. 1956.
7. M. Lopez-Lazaro, "The Warburg effect: Why and howdo cancer cells activate glycolysis in the presence of oxygen?" Anticancer Agents Medicinal Chem., vol. 8, pp. 305-312, Apr. 2008. (Pubitemid 351761435)
8. B. Louie, P. Mork, F. Martin-Sanchez, A. Halevy, and P. Tarczy-Hornoch, "Data integration and genomic medicine," J. Biomed. Informat., vol. 40, pp. 5-16, Feb. 2007.
9. L. Lu, Y. Xia, A. Paccanaro, H. Yu, and M. Gerstein, "Assessing the limits of genomic data integration for predicting protein networks," Genome Res., vol. 15, pp. 945-953, Jul. 2005. (Pubitemid 40994214)
10. A. W. Simonetti, W. J. Melssen, M. van der Graaf, G. J. Postma, A. Heerschap, and L. M. C. Buydens, "A chemometric approach for brain tumor classification using magnetic resonance imaging and spectroscopy," Analytical Chem., vol. 75, pp. 5352-5361, Sep. 2003. (Pubitemid 37280559)
11. M. G. Kounelakis, M. E. Zervakis, G. J. Postma, L. M. C. Buydens, A. Heerschap, and X. Kotsiakis, "Revealing the metabolic profile of brain tumours for diagnosis purposes," in Proc. 31st Annu. Int. IEEE EMBS Conf., 2009, pp. 35-38.
12. S. Khatua, K. M. Peterson, K. M. Brown, C. Lawlor, M. R. Santi, B. LaFleur, D. Dressman, D. A. Stephan, and T. B. MacDonald, "Overexpression of the EGFR/FKBP12/HIF-2- pathway identified in childhood astrocytomas by angiogenesis gene profiling," Cancer Res., vol. 63, pp. 1865-1870, Apr. 2003. (Pubitemid 36460850)
13. T. B. MacDonald, I. F. Pollack, H. Okada, S. Bhattacharva, and J. Lyons-Weiler, "Progression-associated genes in astrocytoma identified by novel microarray gene expression data reanalysis," Methods Molecular Biol., vol. 377, pp. 203-221, 2007. (Pubitemid 350183374)
14. Y. Wang, D. J. Miller, and R. Clarke, "Approaches to working in high-dimensional data spaces: Gene expression microarrays," Brit. J. Cancer, vol. 98, pp. 1023-1028, Feb. 2008. (Pubitemid 351399797)
15. E. Obermayr, F. Sanchez-Cabo, M. K. Tea, C. Singer, M. Krainer, M. Fischer, J. Sehouli, A. Reinthaller, R. Horvat, G. Heinze, D. Tong, and R. Zeillinger, "Assessment of a six gene panel for the molecular detection of circulating tumor cells in the blood of female cancer patients," BMC Cancer, vol. 10, pp. 666-678, Dec. 2010.
16. M. G. Kounelakis, M. E. Zervakis, G. C. Giakos, C. Narayan, S. Marotta, D. Natarajamani, G. J. Postma, L. M. C. Buydens, and X. Kotsiakis, "Targeting brain gliomas energy metabolism for classification purposes," in Proc. IEEE Int. Conf. Imag. Syst. Tech., Thessaloniki, Greece, 2010, pp. 36-40.
17. A. M. Molinaro, R. Simon, and R. M. Pfeiffer, "Prediction error estimation: A comparison of resampling methods," Bioinformatics, vol. 21, pp. 3301-3307, May 2005. (Pubitemid 41418445)
18. W. Chau, A. McIntosh, S. Robinson, M. Schulz, and C. Pantev, "Improving permutation test power for group analysis of spatially filtered MEG data," NeuroImage, vol. 23, pp. 983-996, Jul. 2004. (Pubitemid 39446531)
19. K. Kerr and G. Churchill, "Bootstrapping cluster analysis: Assessing the reliability of conclusions from microarray experiments," in Proc. Nat. Acad. Sci. USA, Jul. 2001, vol. 98, pp. 8961-8965. (Pubitemid 32743852)
20. K. Dobbin and R. Simon, "Sample size planning for developing classifiers using high-dimensional DNA microarray data," Biostatistics, vol. 8, pp. 101-117, Jan. 2007. (Pubitemid 44906105)
21. S. Abe, Support Vector Machines for Pattern Classification. London, U.K.: Springer-Verlag, 2005.
22. I. Kononenko, "Estimating attributes: Analysis and extensions of relief," in Proc. Eur. Conf. Mach. Learning, New York, 1994, pp. 171-182.
23. M. Robnik-Sikonja and I. Kononenko, "Theoretical and empirical analysis of ReliefF and RReliefF," Mach. Learning, vol. 53, pp. 23-69, Nov. 2003.
24. M. G. Kounelakis, M. E. Zervakis, G. J. Postma, L. M. C. Buydens, A. Heerschap, and X. Kotsiakis, "Validation of MRS metabolic markers in the classification of brain gliomas and their correlation to energy metabolism," in Proc. 12th Mediterranean Conf. Med. Biol. Eng. Comput., Chalkidiki, Greece, 2010, pp. 33-36.
25. J. Galarraga, D. J. Loreck, J. F. Graham, R. L. DeLaPaz, B. H. Smith, D. Hallgren, and C. J. Cummins, "Glucose metabolism in human gliomas: Correspondence of in situ and in vitro metabolic rates and altered energy metabolism," Metabolic Brain Disease, vol. 1, pp. 279-291, Dec. 1986.
26. Y. Wang and F. Makedon, "Application of relief-F feature filtering algorithm to selecting informative genes for cancer classification using microarray data," in Proc. IEEE Comput. Syst. Bioinformat. Conf., Stanford, CA, 2004, pp. 497-498.
27. P. Golland, F. Liang, S. Mukherjee, and D. Panchenko, "Permutation tests for classification," in Proc. Annu. Conf. Learning Theory, 2005, pp. 501-515.
28. M. Ojala and G. C. Garriga, "Permutation tests for studying classifier performance," J. Mach. Learning Res., vol. 11, pp. 1833-1863, Jun. 2010.
29. B. Efron and R. J. Tibshirani, An Introduction to the Bootstrap. London, U.K.: Chapman & Hall, 1993.
30. R. Maglietta, A. D'Addabbo, A. Piepoli, F. Perri, S. Liuni, G. Pesole, and N. Ancona, "Selection of relevant genes in cancer diagnosis based on their prediction accuracy," Artif. Intell. Med., vol. 40, pp. 29-44, May 2007. (Pubitemid 46661904)
31. P. Thomas, M. Campbell, A. Kejariwal, H. Mi, B. Karlak, R. Daverman, K. Diemer, A. Muruganujan, and A. Narechania, "PANTHER: A library of protein families and subfamilies indexed by function," Genome Res., vol. 13, pp. 2129-2141, Sep. 2003. (Pubitemid 37161770)
32. J. E. Dominguez, J. F. Graham, C. J. Cummins, D. J. Loreck, J. Galarraga, J. Van der Feen, R. L. DeLaPaz, and B. H. Smith, "Enzymes of glucose metabolism in cultured human gliomas: Neoplasia is accompanied by altered hexokinase, phosphofructokinase, and glucose-6-phosphate dehydrogenase levels," Metabolic Brain Disease, vol. 2, pp. 17-30, Mar. 1987.
33. S. P. Mathupala, Y. H. Ko, and P. L. Pedersen, "Hexokinase II: Cancer's double-edged sword acting as both facilitator and gatekeeper of malignancy when bound to mitochondria," Oncogene, vol. 25, pp. 4777-4786, Aug. 2006.
34. P. L. Pedersen, "Warburg, me and Hexokinase 2: Multiple discoveries of key molecular events underlying one of cancers' most common phenotypes, the 'Warburg Effect', i.e., elevated glycolysis in the presence of oxygen," J. Bioenergetics Biomembranes, vol. 39, pp. 211-222, Jun. 2007.
35. D. A. Tennant, R. V. Duran, H. Boulahbel, and E. Gottlieb, "Metabolic transformation in cancer," Carcinogenesis, vol. 30, pp. 1269-1280, Mar. 2009.
36. S. Zhao, Y. Lin, W. Xu, W. Jiang, Z. Zha, P. Wang, W. Yu, Z. Li, L. Gong, Y. Peng, J. Ding, Q. Lei, K. L. Guan, and Y. Xiong, "Glioma-derived mutations in IDH1 dominantly inhibit IDH1 catalytic activity and induce HIF-1a," Science, vol. 324, pp. 261-265, Apr. 2009.
37. G. L. Semenza, B. H. Jiang, S. W. Leung, R. Passantino, J. P. Concordet, P. Maire, and A. Giallongo, "Hypoxia response elements in the aldolase A, enolase 1, and lactate dehydrogenase A gene promoters contain essential binding sites for hypoxia-inducible factor 1," J. Biological Chem., vol. 20, pp. 32529-32537, Dec. 1996.
38. H. Pelicano, D. S. Martin, R. H. Xu, and P. Huang, "Glycolysis inhibition for anticancer treatment," Oncogene, vol. 25, pp. 4633-4646, Aug. 2006.
39. T. Yanagawa, T. Funasaka, S. Tsutsumi, H. Watanabe, and A. Raz, "Novel roles of the autocrine motility factor/phosphoglucose isomerase in tumor malignancy," Endocrine Related Cancer, vol. 11, pp. 749-759, Dec. 2004. (Pubitemid 40065548)
40. A. J. Levine and A. M. Puzio-Kuter, "The control of the metabolic switch in cancers by oncogenes and tumor suppressor genes," Science, vol. 330, pp. 1340-1344, Dec. 2010.
41. M. C. Simon, "Coming up for air: HIF-1 and mitochondrial oxygen consumption," Cell Metabolism, vol. 3, pp. 150-151, Mar. 2006.
42. J. W. Kim, I. Tchernyshyov, G. L. Semenza, and C. V. Dang, "HIF-1-mediated expression of pyruvate dehydrogenase kinase: A metabolic switch required for cellular adaptation to hypoxia," Cell Metabolism, vol. 3, pp. 177-185, Mar. 2006.
43. S. M. Lee, J. H. Kim, E. J. Cho, and H. D. Youn, "A nucleocytoplasmic malate dehydrogenase regulates p53 transcriptional activity in response to metabolic stress," Cell Death Differentiation, vol. 16, pp. 738-748, Feb. 2009.
44. R. H. Xu, H. Pelicano, Y. Zhou, J. S. Carew, L. Feng, K. N. Bhalla, M. J. Keating, and P. Huang, "Inhibition of glycolysis in cancer cells: A novel strategy to overcome drug resistance associated with mitochondrial respiratory defect and hypoxia," Cancer Res., vol. 65, pp. 613-621, Jan. 2005.
45. A. Wolf, S. Agnihotri, and A. Guha, "Targeting metabolic remodeling in glioblastoma multiforme," Oncotarget, vol. 1, pp. 552-562, Oct. 2010.
46. P. Seth, A. Grant, J. Tang, E. Vinogradov, X. Wang, R. Lenkinski, and V. P. Sukhatme, "On-target inhibition of tumor fermentative glycolysis as visualized by hyperpolarized pyruvate," Neoplasia, vol. 13, pp. 60-71, Jan. 2011.
47. M. G. Kounelakis, M. E. Zervakis, G. C. Giakos, and X. Kotsiakis, "The role of glycolysis-related genes in brain gliomas treatment design," presented at the 5th Eur. Conf. Int. Fed. Med. Biol. Eng., Budapest, Hungary, 2011.